/Companies

TernaryTx

4 known investors

Find your way into TernaryTx

Sign up to see every warm intro you have to TernaryTx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the TernaryTx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms. The company serves pharmaceutical and biotech organizations seeking computational approaches to identify novel therapeutic targets.

Founders & leadership

CTChris Tame
Chris TameCEO & Co-FounderChris Tame is CEO and co-founder of Ternary, which develops AI-driven drug discovery technology. He has experience building machine learning products for drug design and target identification, with expertise in targeted protein degradation approaches.
APAndrew Potterton
Andrew PottertonCTO & Co-FounderAndrew Potterton is a structural bioinformatician with 10 years of industry experience who co-founded Ternary, an AI-driven drug discovery platform for targeted protein degradation.

Investors · 4

Frequently asked questions

What does TernaryTx do?
Ternary develops AI-driven drug discovery technology focused on targeted protein degradation and induced proximity platforms. The company serves pharmaceutical and biotech organizations seeking computational approaches to identify novel therapeutic targets.
Who founded TernaryTx?
TernaryTx was founded by Chris Tame, Andrew Potterton.
Who are TernaryTx's investors?
TernaryTx's investors include Daphni, i&i Biotech Fund, Pace Ventures, UK Innovation & Science Seed Fund.